One World Pharma Completes Merger
February 25 2019 - 10:03AM
InvestorsHub NewsWire
One World Pharma Completes
Merger
Acquires Colombian Cannabis
Operator Preparing for Expansion and First Harvest
LAS VEGAS, NV -- February 25, 2019 -- InvestorsHub NewsWire
-- One World Pharma Inc. (OTC Pink:
OWPC), is pleased to announce that it has
acquired One World Pharma SAS, a fully licensed cannabis cultivator
and manufacturer based in Popayan, Colombia, in a merger
transaction that closed on February 21, 2019. Under the terms of
the merger agreement, the stockholders of OWP Ventures, Inc., which
is the parent company of One World Pharma SAS, will be issued an
aggregate of 39,475,398 shares of common stock of One World Pharma,
Inc. After giving effect to the merger, One World Pharma,
Inc. has 39,922,898 shares of common stock issued and
outstanding.
Colombia is considered by many to be an ideal growing location
for cannabis, hemp and related products. The nation’s equatorial
climate, pro-cannabis government regulations, and talented local
population provide the core ingredients to produce high crop yields
and quality product for export at a low cost, allowing for
significant margin regardless of changing market conditions.
One World Pharma SAS has been developing relationships and
infrastructure in Colombia for two years, working hand in hand with
the indigenous population and government officials. The company
holds all four key government issued licenses for the cultivation
of psychoactive high THC, cultivation of non-psychoactive low THC,
manufacture of cannabis derivatives, and seed use.
“One World Pharma has exceeded our expectations as a thriving,
rapidly expanding licensed Colombian medical cannabis producer,”
stated Craig Ellins, CEO, One World Pharma Inc. “The Company is
ideally situated to capitalize on the Colombian opportunity with
significant production capacity and registered strains. We will be
utilizing the entire plant in a synergistic marriage of U.S.
based cultivation and manufacturing technology and the hospitable
cultivation environment that Colombia provides. We are
committed to building One World Pharma into a key player in the
international supply chain, as global branded consumer products,
beverage and pharmaceutical companies call for a truly industrial
level of supply.”
“We look forward to sharing the results of our first harvest,”
added Ellins.
About One World Pharma
One World Pharma Inc. is the U.S. parent company of One World
Pharma SAS, a licensed cannabis and hemp producer with offices and
operations in Bogota and Popayan, Colombia. One World Pharma
planted its first crop of cannabis in 2018 at its cultivation site
in Popayan, Colombia, which it expects to begin harvesting in the
first quarter of 2019. The Company intends to supply the
highest quality cannabis and hemp derivatives in crude oil,
distillate and isolate forms for industrial scale production
to serve global cannabis demand. Its products will be produced and
tested to GMP and ISO standards.
Investors are advised that from time to time the Company may
provide information about its operations through its website
at www.oneworldpharma.com.
Information about Forward-Looking
Statements
This press release contains "forward-looking statements" that
include information relating to future events. Forward-looking
statements should not be read as a guarantee of future performance
or results and will not necessarily be accurate indications of the
times at, or by, which that performance or those results will be
achieved. Forward-looking statements are based on information
available at the time they are made and/or management's good faith
belief as of that time with respect to future events and are
subject to risks and uncertainties that could cause actual
performance or results to differ materially from those expressed
in, or suggested by, the forward-looking statements. Important
factors that could cause these differences include, but are not
limited to: the Company's need for additional funding, the demand
for the Company's products, governmental regulation of the cannabis
industry, the Company's ability to maintain customer and strategic
business relationships, the impact of competitive products and
pricing, risks related to operating in
Colombia, growth in targeted
markets, the adequacy of the Company's liquidity and financial
strength to support its growth, and other risks that may be
detailed from time-to-time in the Company's filings with the United
States Securities and Exchange Commission. For a more detailed
description of the risk factors and uncertainties affecting One
World Pharma, please refer to the Company's Current Report on 8-K
filed with the Securities and Exchange Commission on February 25,
2019, which is available at www.sec.gov. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
One World Pharma Company Contact:
Mimi Tekabe One World Pharma Inc.1.800.605.3210
www.oneworldpharma.com One World Pharma Investor Relations & Financial Media Integrity Media Inc.
info@integrityir.com Toll Free: (888) 216-3595
www.IntegrityIR.com
One World Products (QB) (USOTC:OWPC)
Historical Stock Chart
From Mar 2024 to Apr 2024
One World Products (QB) (USOTC:OWPC)
Historical Stock Chart
From Apr 2023 to Apr 2024